Cytovation

Developing CyPep-1, the first synthetic peptide engineered to selectively target tumor cell membranes based on their altered molecular composition.

HQ location

Bergen, Norway

Website

Launch date

Jun 2001

Employees

Enterprise value

$100m

Company register number

983644600

https://twitter.com/cytovation https://www.linkedin.com/company/cytovation-asa/

Authorizing premium user...